-
Changes are coming in 2025 to the federal healh insurance program that covers Americans age 65 and older. Two Medicare experts spoke on "The Florida Roundup" about what to expect.
-
This week on "The Florida Roundup," we spoke about some of the biggest changes coming to Medicare in 2025, along with how Florida policy-making could influence national politics in the coming years.
-
Most people taking drugs like Ozempic and Wegovy have shed significant pounds. But obesity experts say that roughly 20% of patients — as many as 1 in 5 — may not see robust results with the medications.
-
Medicare officials defend the use of home visits that often spot medical conditions that are never treated.
-
Every year, Medicare officials encourage beneficiaries to shop around for their drug coverage. Few take the time. This year, it might be more important than ever.
-
People will be able to sign up for 2025 coverage between Oct. 15 and Dec. 7. Experts say the potential changes make it important for shoppers to study closely any coverages they expect to renew.
-
It starts earlier and runs longer than anywhere else in the U.S., according to UF’s Emerging Pathogens Institute. Most older adults, who are vulnerable to the disease, haven’t been vaccinated yet.
-
The GUIDE Model is designed to facilitate comprehensive, coordinated care that improves the quality of life for people with dementia and reduces the strain on their unpaid caregivers.
-
Rising health care costs are fueling anxiety among older Americans covered by Medicare. They’re right to be concerned.
-
The Department of Justice charged 193, including 76 licensed medical professionals, throughout the country as part of the action. Many of those indicted are from Florida.
-
The technology has generated notices with errors, sent Medicaid paperwork to the wrong addresses, and been frozen for hours at a time, according to state audits, court documents, and interviews.
-
The White House has launched an initiative on women’s health. Studying the health of older women, a largely neglected group in medical research, should be a priority.